Thyrocare Technologies has informed that Board of Directors vide Circular resolution passed on May 21, 2025, has approved the allotment of 996 Equity Shares pursuant to the Employee Stock Option Scheme of the Company. These shares shall rank pari passu in all respects with the existing equity shares of the Company. Following the said allotment, the Issued, Subscribed and Paid-up Equity Share Capital of the Company stands increased as enclosed.
The above information is a part of company’s filings submitted to BSE.
